Outcome measures in systemic lupus erythematosus

Area of Science:

• Rheumatology
• Clinical Immunology
• Health Outcomes Research

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease with variable multisystem involvement and risk of organ damage.
• Standardized SLE disease activity indices are crucial for research but lack widespread clinical integration.
• Existing measures include traditional indices, dichotomous composite indices, and emerging continuous scoring tools.

Purpose of the Study:

• To review the evolution of SLE outcome measures.
• To evaluate the strengths and limitations of current SLE assessment tools.
• To discuss future directions for comprehensive SLE assessment strategies.

Main Methods:

• Literature review synthesizing the development of SLE outcome measures.
• Evaluation of traditional and emerging SLE disease activity indices.
• Discussion of organ-specific measures, patient-reported outcomes, and damage indices.

Main Results:

• Traditional indices provide objective disease activity measures.
• Composite indices differentiate therapeutic response.
• Emerging tools like SLE Disease Activity Score offer continuous scoring aligned with treat-to-target goals.
• Patient-reported outcomes and damage indices complement global assessments but are underutilized.

Conclusions:

• There is a need for unified, actionable SLE assessment metrics.
• Future directions include integrating biomarkers, imaging, and digital health innovations.
• Developing comprehensive, clinically feasible, multidimensional assessment strategies is essential for improved SLE management.